Population Genomics Initiatives Powered by Helix
Helix partners with leading health systems across the country to bring population-scale genomic programs to their communities.
Our Partners
The Healthy Nevada Project
Renown IHI
The Healthy Nevada Project, created by the Renown Institute for Health Innovation (IHI), is a clinical study offering no-cost genetic screening to residents of Nevada. This study aims to create a robust set of data—genomics, medical, and environmental—that enables researchers at Renown Health and the Desert Research Institute to advance the standard of care in Nevada and the nation. Participants in this study are given insights about their genetic ancestry and the potential influence of their DNA on certain wellness traits; among those who opt in to receive potentially medically relevant information, some participants will also learn about their genetic predispositions for certain diseases linked to heart disease and various cancers.
In our DNA SC
Medical University of South Carolina
The Medical University of South Carolina (MUSC) launched their population genomics program, In Our DNA SC, in partnership with Helix. The large-scale (100,000 participant) program is designed to improve health care outcomes by integrating genetic insights into clinical care and research. MUSC will leverage Helix's unique Sequence Once, Query Often™ model and its end-to-end integration platform to enable immediate clinical application and continual on-demand use of genetic insights throughout a patient's life. The robust clinico-genomic dataset developed from consenting participants will also be used to pioneer and further advance genomics research.
myGenetics
HealthPartners
HealthPartners has created myGenetics, a population genomics program, to provide important health information to families across Minnesota and surrounding states. As a large-scale community health research program, myGenetics has partnered with Helix to better understand how DNA impacts health and how it may be used to provide more personalized care to HealthPartners patients. The program aligns with HealthPartners ongoing drive to deliver simple, personalized, affordable care while advancing precision medicine and greater health equity. The myGenetics program is available to HealthPartners patients over the age of 18 and aims to enroll more than 100,000 participants over four years.
genoME®
Memorial Hermann
Memorial Hermann Health System's population genomics research program, genoME, is designed to utilize DNA information to look for hidden health risks. Information will be used to help the health system better understand the health of its overall population. It will give patients and their providers insight into their health to personalize patient care and create proactive care plans to address key risk factors. It will have an anticipated 100,000 participants and will be one of the largest population health research programs in Texas. The program will be used by Memorial Hermann to redefine health care for the communities the system has served for more than 115 years.
The Gene Health Project
WellSpan Health
WellSpan Health launched a comprehensive population genomics program designed to improve patient healthcare outcomes by integrating genetic insights into clinical care and research in Pennsylvania. The genetic reports made available by this program may allow patients and their health providers to develop precision health care plans to proactively mitigate serious health risk conditions and take a more preventative and individualized approach to their care. WellSpan will leverage Helix's end-to-end genomic platform and unique Sequence Once, Query Often™ model.
DNA Answers
St. Luke's University Health Network
St. Luke's University Health Network is offering community health research program DNA Answers to provide precision medicine opportunities to patients in Pennsylvania and New Jersey. The program initially aims to enroll 100,000 participants over four years. The individuals who participate will be provided with important health information about their potential risks for serious health conditions such as certain types of cardiovascular disease and cancer, allowing them to make proactive decisions in conjunction with their healthcare provider.
- Genetic Insights Project
Genetic Insights Project
Nebraska Medicine
Nebraska Medicine, the state's largest hospital and leading academic health network, is partnering with Helix on The Genetic Insights Project to drive precision medicine for all individuals in Nebraska. The research program will identify participants' risk for a variety of cancers and other potentially life-threatening diseases with a single screening, with the goal of not only helping to improve the lives of individual patients but identify trends for everyone across the region.
GeneConnect
Cone Health
Cone Health, a not-for-profit health care network serving people in the North Carolina Piedmont region, launched a population genomics screening program with Helix. The program will put precision medicine to work in Alamance, Forsyth, Guilford, Rockingham and Randolph counties and beyond. The joint project will enroll 100,000 healthy people over a 5-year period. Genetic screening will provide medical insights for Cone Health patients using Helix's population genomics platform.
ImagineYou
Sanford Health
As the largest rural health system in the United States, Sanford Health is partnering with Helix on their population genomics program ImagineYou to drive more personalized healthcare for communities in the Upper Midwest. Together, the partners aim to enroll 100,000 participants, providing actionable, early and preventive medical care insights for Sanford Health patients with Helix's population genomics platform. The program will build on the success of Sanford Imagenetics, which was established in 2014 and has served more than 70,000 patients.
- Ohio State Genomic Health
Ohio State Genomic Health
The Ohio State University Wexner Medical Center
The Ohio State University Wexner Medical Center and Helix are partners on the largest precision health initiative in Ohio, which aims to drive better health outcomes and more personalized care for all individuals in the state. The program will enroll 100,000 participants over four years and will provide important information about potential risks for health conditions by screening for variants in genes associated with breast and ovarian cancer, colorectal cancer and high cholesterol.
Precisely You
WakeMed Health & Hospitals
Helix and WakeMed, a nationally recognized not-for-profit health system based in Raleigh, N.C., have launched a precision medicine community program called PreciselyYou. This initiative strives to transform health outcomes by making individualized care accessible to everyone, improving disease prevention, and supporting local health research efforts for residents of Wake County and beyond.
DNA Discovery
TriHealth
TriHealth, a leading health system in Cincinnati, Ohio, has joined the Helix Research Network® to advance population genomics. Through its hospitals, physician practices, and research division, TriHealth is integrating genetic insights into clinical and preventive care. This initiative helps providers identify risks for conditions like cancer and heart disease, improving early detection and prevention.
DNA Insights
Parkview Health
Parkview Health, a nonprofit health system with 14 hospitals and more than 45 clinical specialties in Northeast Indiana, has created DNA Insights to advance genomic research and precision medicine. Guided by its mission to improve health and inspire well-being, Parkview is committed to trust, compassion, innovation, and community stewardship. Parkview will integrate genetic insights into patient care to identify risks for CDC Tier 1 conditions—hereditary breast and ovarian cancer, Lynch syndrome, and familial hypercholesterolemia.
GenoWell
Rochester Regional Health
Rochester Regional Health, an integrated health services organization serving Western New York and the Finger Lakes, has partnered with Helix to offer GenoWell — a community health research program aiming to enhance patient care through genetic insights. Guided by its purpose to uplift humanity through care for the community, Rochester Regional Health will integrate genomics into clinical practice. By incorporating genetic insights, the partnership will help early detection, allowing for more proactive and personalized patient care.
- OurGenes Study
OurGenes Study
Princess Margaret Cancer Centre at University Health Network
UHN is Canada's Hospital. With 10 sites and more than 44,000 TeamUHN members, UHN consists of Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, The Michener Institute of Education and West Park Healthcare Centre. As Canada's top research hospital, the scope of biomedical research and complexity of cases at UHN have made it a national and international source for discovery, education and patient care. The OurGenes Study aims to enroll up to 100,000 participants over five years, advancing precision medicine and early detection of hereditary health risks.
Interested in partnering with Helix?
Contact us to learn how we can work together to bring population-scale genomic programs to your community.